REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Novo S.A. Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Novo S.A. is an enterprise located in Poland, with the main office in Tychy. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on July 15, 2010. The total number of employees is currently 204 (2021). From the latest financial highlights, Novo S.A. reported a net sales revenue increase of 8.41% in 2022. Its’ total assets recorded a growth of 7.48%. The net profit margin of Novo S.A. decreased by 0.53% in 2022.

Headquarters
Ul. Mikolowska 232
Tychy; Slaskie; Postal Code: 43-100

Contact Details: Purchase the Novo S.A. report to view the information.

Website: http://novo-sa.pl/

Basic Information
Total Employees:
Purchase the Novo S.A. report to view the information.
Outstanding Shares:
Purchase the Novo S.A. report to view the information.
Registered Capital:
Purchase the Novo S.A. report to view the information.
Financial Auditors:
Purchase the Novo S.A. report to view the information.
Incorporation Date:
July 15, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Novo S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
8.41%
Total operating revenue
8.39%
Operating profit (EBIT)
22.55%
EBITDA
18.52%
Net Profit (Loss) for the Period
-25.99%
Total assets
7.48%
Total equity
1.19%
Operating Profit Margin (ROS)
0.19%
Net Profit Margin
-0.53%
Return on Equity (ROE)
-7.8%
Debt to Equity Ratio
10.82%
Quick Ratio
0%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?